Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rasburicase in Adult Leukemia or Lymphoma
NCT00631579Phase 2Completed
- Sponsor
- Sanofi
- Start
- Apr 2003
- Primary completion
- Jun 2004
- Modality
- Replacement Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of rasburicase in hyperuricemia, sponsored by Sanofi. Started Apr 2003; status: completed.
02
Drugs
rasburicase
03
Conditions
hyperuricemia
Beyond the preview
Go deeper on NCT00631579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631579.